According to Future Market Insights, the global Brain Computing Interfaces Market is set to reach USD 1.8 billion in 2023. With a growth rate of 13.6%, the brain computing interfaces market is projected to reach USD 6.5 billion by 2033.

A significant amount of research has been conducted on brain-computer interfaces (BCIs) in recent years. A brain-computer interface allows humans to interact with technology using their thoughts alone, establishing a direct link that connects the brain to an external device.

Using BCIs raises interesting ethical and policy issues, like cognitive liberty, identity preservation, and access. For the development, deployment, and use of BCIs, researchers, policymakers, and ethicists must discuss their ethical implications.

Among other applications, BCIs have the potential to improve worker safety, improve productivity, and improve human-robot collaboration.

For example, BCIs can be used to operate machinery directly from the brain or to monitor cognitive workload as a means of preventing accidents and improving the quality of work performed by employees.

BCIs can provide immersive and interactive experiences that can transform gaming and entertainment. Virtual reality experiences, neurofeedback-equipped entertainment platforms, and brain-controlled games are likely to transform consumer engagement with digital media in the coming years.

About CraniUS

About CraniUS™

CraniUS™ was founded May 2021 in Baltimore, MD, as a byproduct of the emerging field known as “Neuroplastic and Reconstructive Surgery”, through the vision, insight, and pioneering work of Dr. Chad Gordon. CraniUS™ has raised over $24M to date, been issued 7 patents, and is currently in the midst of a Series B raise.

The NeuroPASS™ device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.